NASDAQ:SLRX
Delisted

Salarius Pharmaceuticals Stock Insider Trading

etoro logo Buy SLRX
*Your capital is at risk
$0.84
+0 (+0%)
At Close: Apr 14, 2026

Salarius Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.99. In total, the insiders bought 1.66B and sold 27 SLRX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
99.99
Buy 1.66B shares
Sell 27 shares
98% Buy Activity
Weak Negative Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
May 26, 2022
Buy
Common Stock
P-Purchase
Arthur David J.
Chief Executive Officer
CEO / President 10 392
Value: $2K
May 26, 2022
Buy
Common Stock
P-Purchase
Arthur David J.
Chief Executive Officer
CEO / President 708
Value: $127
May 26, 2022
Buy
Common Stock
P-Purchase
Arthur David J.
Chief Executive Officer
CEO / President 18 600
Value: $3K
May 26, 2022
Buy
Common Stock
P-Purchase
Arthur David J.
Chief Executive Officer
CEO / President 3 400
Value: $612
May 26, 2022
Buy
Common Stock
P-Purchase
Arthur David J.
Chief Executive Officer
CEO / President 3 400
Value: $612
May 26, 2022
Buy
Common Stock
P-Purchase
Arthur David J.
Chief Executive Officer
CEO / President 18 600
Value: $3K
May 26, 2022
Buy
Common Stock
P-Purchase
Arthur David J.
Chief Executive Officer
CEO / President 708
Value: $127
May 26, 2022
Buy
Common Stock
P-Purchase
Arthur David J.
Chief Executive Officer
CEO / President 10 392
Value: $2K
May 26, 2022
Buy
Common Stock
P-Purchase
Arthur David J.
Chief Executive Officer
CEO / President 10 800
Value: $2K
May 03, 2022
Buy
Common Stock
A-Award
Arthur David J.
Chief Executive Officer
CEO / President 10 000
Value: $2K
May 03, 2022
Buy
Common Stock
A-Award
Rosenblum Mark J
Exec Vp Finance, CFO
C-Suite Officer 10 000
Value: $2K
May 03, 2022
Buy
Common Stock
A-Award
Rosenblum Mark J
Exec Vp Finance, CFO
C-Suite Officer 10 000
Value: $2K
May 03, 2022
Buy
Common Stock
A-Award
Arthur David J.
Chief Executive Officer
CEO / President 10 000
Value: $2K
Mar 03, 2022
Buy
Common Stock
P-Purchase
Rosenblum Mark J
Exec Vp Finance, CFO
C-Suite Officer 76 246
Value: $29.8K
Mar 03, 2022
Buy
Common Stock
P-Purchase
Arthur David J.
Chief Executive Officer
CEO / President 139 488
Value: $54.5K
Mar 03, 2022
Buy
Common Stock
P-Purchase
Arthur David J.
Chief Executive Officer
CEO / President 139 488
Value: $54.5K
Mar 03, 2022
Buy
Common Stock
P-Purchase
Rosenblum Mark J
Exec Vp Finance, CFO
C-Suite Officer 76 246
Value: $29.8K
Jan 20, 2022
Buy
Stock Option (right to buy)
A-Award
Mcvicar William K.
Director
Director 30 000
Value: $14.4K
Jan 20, 2022
Buy
Stock Option (right to buy)
A-Award
Lieber Jonathan I
Director
Director 30 000
Value: $14.4K
Aug 21, 2020
Buy
Common Stock
P-Purchase
Hanish Arnold C
Director
Director 4 000
Value: $4K
Aug 21, 2020
Buy
Common Stock
P-Purchase
Hanish Arnold C
Director
Director 4 000
Value: $4K
Feb 11, 2020
Buy
Common Stock
P-Purchase
Hanish Arnold C
Director
Director 4 350
Value: $5K
Feb 11, 2020
Buy
Common Stock
P-Purchase
Hanish Arnold C
Director
Director 4 350
Value: $5K
Nov 25, 2019
Buy
Common Stock
P-Purchase
Hanish Arnold C
Director
Director 3 000
Value: $10.8K
Nov 25, 2019
Buy
Common Stock
P-Purchase
Hanish Arnold C
Director
Director 3 000
Value: $10.8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT SALARIUS PHARMACEUTICALS INC.
Salarius Pharmaceuticals
Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategi...
GOLDEN STAR
Ticker Change Signal Date
FCX
$62.63
7.46% Jul 31
MC
$67.08
2.40% Jul 31
ARW
$212.85
6.96% Jul 30
BIIB
$202.19
3.10% Jul 24
F
FERG
$230.67
10.77% Jul 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE